In the downstream pathways, IL-17 overexpression promoted the survival and maturation of fibroblasts and immune cells in the synovium, thereby aggravating synovial inflammation [90], which ran through the whole process of RA (76). The gene discussed is IL17A; the disease is rheumatoid arthritis.